{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,17]],"date-time":"2026-02-17T11:44:53Z","timestamp":1771328693004,"version":"3.50.1"},"reference-count":55,"publisher":"Elsevier BV","issue":"10","license":[{"start":{"date-parts":[[2022,10,1]],"date-time":"2022-10-01T00:00:00Z","timestamp":1664582400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,10,1]],"date-time":"2022-10-01T00:00:00Z","timestamp":1664582400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,6,11]],"date-time":"2022-06-11T00:00:00Z","timestamp":1654905600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100001700","name":"Ministry of Education, Culture, Sports, Science and Technology","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001700","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100012036","name":"Lotte Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100012036","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["celltherapyjournal.org","clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Cytotherapy"],"published-print":{"date-parts":[[2022,10]]},"DOI":"10.1016\/j.jcyt.2022.05.009","type":"journal-article","created":{"date-parts":[[2022,6,18]],"date-time":"2022-06-18T07:26:29Z","timestamp":1655537189000},"page":"1013-1025","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":19,"title":["Advantages of peripheral blood stem cells from unrelated donors versus bone marrow transplants in outcomes of adult acute myeloid leukemia patients"],"prefix":"10.1016","volume":"24","author":[{"given":"Tomoyasu","family":"Jo","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9662-5093","authenticated-orcid":false,"given":"Yasuyuki","family":"Arai","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8959-6271","authenticated-orcid":false,"given":"Tadakazu","family":"Kondo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shohei","family":"Mizuno","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shigeki","family":"Hirabayashi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yoshihiro","family":"Inamoto","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8661-3179","authenticated-orcid":false,"given":"Noriko","family":"Doki","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Takahiro","family":"Fukuda","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yukiyasu","family":"Ozawa","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yuta","family":"Katayama","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yoshinobu","family":"Kanda","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kentaro","family":"Fukushima","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ken-ichi","family":"Matsuoka","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Satoru","family":"Takada","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Masashi","family":"Sawa","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Takashi","family":"Ashida","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Makoto","family":"Onizuka","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tatsuo","family":"Ichinohe","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4404-2870","authenticated-orcid":false,"given":"Yoshiko","family":"Atsuta","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6704-3633","authenticated-orcid":false,"given":"Junya","family":"Kanda","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1602-9775","authenticated-orcid":false,"given":"Masamitsu","family":"Yanada","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"8393","key":"10.1016\/j.jcyt.2022.05.009_bib0001","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1016\/S0140-6736(84)92009-9","article-title":"How does bone-marrow transplantation cure leukaemia?","volume":"2","author":"Gale","year":"1984","journal-title":"Lancet"},{"issue":"2","key":"10.1016\/j.jcyt.2022.05.009_bib0002","first-page":"35","article-title":"Hematopoietic cell transplantation in adults with acute myeloid leukemia: A review of the results from various nationwide registry studies in Japan","volume":"4","author":"Arai","year":"2021","journal-title":"Blood Cell Therapy"},{"key":"10.1016\/j.jcyt.2022.05.009_bib0003","author":"Phelan"},{"issue":"16","key":"10.1016\/j.jcyt.2022.05.009_bib0004","doi-asserted-by":"crossref","first-page":"1487","DOI":"10.1056\/NEJMoa1203517","article-title":"Peripheral-blood stem cells versus bone marrow from unrelated donors","volume":"367","author":"Anasetti","year":"2012","journal-title":"N Engl J Med"},{"issue":"7","key":"10.1016\/j.jcyt.2022.05.009_bib0005","doi-asserted-by":"crossref","first-page":"1651","DOI":"10.1038\/s41409-021-01227-8","article-title":"Hematopoietic cell transplantation and cellular therapy survey of the EBMT: monitoring of activities and trends over 30 years","volume":"56","author":"Passweg","year":"2021","journal-title":"Bone Marrow Transplant"},{"issue":"9","key":"10.1016\/j.jcyt.2022.05.009_bib0006","doi-asserted-by":"crossref","first-page":"2541","DOI":"10.1182\/blood.V97.9.2541","article-title":"Experiences of donors enrolled in a randomized study of allogeneic bone marrow or peripheral blood stem cell transplantation","volume":"97","author":"Rowley","year":"2001","journal-title":"Blood"},{"issue":"7","key":"10.1016\/j.jcyt.2022.05.009_bib0007","doi-asserted-by":"crossref","first-page":"709","DOI":"10.1038\/sj.bmt.1704418","article-title":"Mobilized blood cells vs bone marrow harvest: experience compared in 171 donors with particular reference to pain and fatigue","volume":"33","author":"Karlsson","year":"2004","journal-title":"Bone Marrow Transplant"},{"issue":"12","key":"10.1016\/j.jcyt.2022.05.009_bib0008","doi-asserted-by":"crossref","first-page":"1461","DOI":"10.1016\/j.bbmt.2007.08.006","article-title":"Peripheral blood grafts from unrelated donors are associated with increased acute and chronic graft-versus-host disease without improved survival","volume":"13","author":"Eapen","year":"2007","journal-title":"Biol Blood Marrow Transplant"},{"issue":"1","key":"10.1016\/j.jcyt.2022.05.009_bib0009","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1016\/j.bbmt.2014.09.006","article-title":"Long-term survival after transplantation of unrelated donor peripheral blood or bone marrow hematopoietic cells for hematologic malignancy","volume":"21","author":"Eapen","year":"2015","journal-title":"Biol Blood Marrow Transplant"},{"issue":"8","key":"10.1016\/j.jcyt.2022.05.009_bib0010","doi-asserted-by":"crossref","first-page":"e177","DOI":"10.1016\/j.bbmt.2020.04.013","article-title":"Current Use of and Trends in Hematopoietic Cell Transplantation in the United States","volume":"26","author":"D'Souza","year":"2020","journal-title":"Biol Blood Marrow Transplant"},{"issue":"10","key":"10.1016\/j.jcyt.2022.05.009_bib0011","doi-asserted-by":"crossref","first-page":"2062","DOI":"10.1038\/leu.2015.212","article-title":"Ruxolitinib in corticosteroid-refractory graft-versus-host disease after allogeneic stem cell transplantation: a multicenter survey","volume":"29","author":"Zeiser","year":"2015","journal-title":"Leukemia"},{"issue":"21","key":"10.1016\/j.jcyt.2022.05.009_bib0012","doi-asserted-by":"crossref","first-page":"2243","DOI":"10.1182\/blood-2017-07-793786","article-title":"Ibrutinib for chronic graft-versus-host disease after failure of prior therapy","volume":"130","author":"Miklos","year":"2017","journal-title":"Blood"},{"issue":"6","key":"10.1016\/j.jcyt.2022.05.009_bib0013","doi-asserted-by":"crossref","first-page":"1126","DOI":"10.1038\/s41409-020-0818-4","volume":"55","author":"Nava","year":"2020","journal-title":"Bone Marrow Transplant"},{"key":"10.1016\/j.jcyt.2022.05.009_bib0014","unstructured":"Hematopoietic Cell Transplantation in Japan. Annual Report of Nationwide Survey 2020: The Japanese Data Center for Hematopoietic Cell Transplantation\/The Japan Society for Hematopoietic. Cell Transplantation. http:\/\/www.jdchct.or.jp\/data\/report\/2020\/"},{"issue":"2","key":"10.1016\/j.jcyt.2022.05.009_bib0015","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1007\/s12185-017-2341-y","article-title":"Prospective observational study on the first 51 cases of peripheral blood stem cell transplantation from unrelated donors in Japan","volume":"107","author":"Goto","year":"2018","journal-title":"Int J Hematol"},{"issue":"1","key":"10.1016\/j.jcyt.2022.05.009_bib0016","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1007\/s12185-015-1894-x","article-title":"Introduction of Transplant Registry Unified Management Program 2 (TRUMP2): scripts for TRUMP data analyses, part I (variables other than HLA-related data)","volume":"103","author":"Atsuta","year":"2016","journal-title":"Int J Hematol"},{"issue":"1","key":"10.1016\/j.jcyt.2022.05.009_bib0017","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1007\/s12185-015-1907-9","article-title":"Scripts for TRUMP data analyses. Part II (HLA-related data): statistical analyses specific for hematopoietic stem cell transplantation","volume":"103","author":"Kanda","year":"2016","journal-title":"Int J Hematol"},{"issue":"3","key":"10.1016\/j.jcyt.2022.05.009_bib0018","first-page":"250","article-title":"Chronic graft-versus-host disease and other late complications of bone marrow transplantation","volume":"28","author":"Sullivan","year":"1991","journal-title":"Semin Hematol"},{"issue":"6","key":"10.1016\/j.jcyt.2022.05.009_bib0019","first-page":"825","article-title":"1994 Consensus Conference on Acute GVHD Grading","volume":"15","author":"Przepiorka","year":"1995","journal-title":"Bone Marrow Transplant"},{"issue":"8","key":"10.1016\/j.jcyt.2022.05.009_bib0020","doi-asserted-by":"crossref","first-page":"1333","DOI":"10.1182\/blood-2014-10-609032","article-title":"Composite end point of graft-versus-host disease-free, relapse-free survival after allogeneic hematopoietic cell transplantation","volume":"125","author":"Holtan","year":"2015","journal-title":"Blood"},{"issue":"12","key":"10.1016\/j.jcyt.2022.05.009_bib0021","doi-asserted-by":"crossref","first-page":"1813","DOI":"10.1086\/588660","volume":"46","author":"De Pauw","year":"2008","journal-title":"Clin Infect Dis"},{"issue":"3","key":"10.1016\/j.jcyt.2022.05.009_bib0022","doi-asserted-by":"crossref","first-page":"601","DOI":"10.1080\/10428194.2017.1357173","article-title":"Effect of cytogenetic risk status on outcomes for patients with acute myeloid leukemia undergoing various types of allogeneic hematopoietic cell transplantation: an analysis of 7812 patients","volume":"59","author":"Yanada","year":"2018","journal-title":"Leuk Lymphoma"},{"issue":"3","key":"10.1016\/j.jcyt.2022.05.009_bib0023","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1016\/j.bbmt.2008.12.497","article-title":"Reduced-intensity conditioning regimen workshop: defining the dose spectrum. Report of a workshop convened by the center for international blood and marrow transplant research","volume":"15","author":"Giralt","year":"2009","journal-title":"Biol Blood Marrow Transplant"},{"issue":"11","key":"10.1016\/j.jcyt.2022.05.009_bib0024","doi-asserted-by":"crossref","first-page":"4200","DOI":"10.1182\/blood.V99.11.4200","article-title":"The clinical significance of human leukocyte antigen (HLA) allele compatibility in patients receiving a marrow transplant from serologically HLA-A, HLA-B, and HLA-DR matched unrelated donors","volume":"99","author":"Morishima","year":"2002","journal-title":"Blood"},{"issue":"4","key":"10.1016\/j.jcyt.2022.05.009_bib0025","doi-asserted-by":"crossref","first-page":"364","DOI":"10.1200\/JCO.2014.57.2446","article-title":"Bone marrow or peripheral blood for reduced-intensity conditioning unrelated donor transplantation","volume":"33","author":"Eapen","year":"2015","journal-title":"J Clin Oncol"},{"issue":"12","key":"10.1016\/j.jcyt.2022.05.009_bib0026","doi-asserted-by":"crossref","first-page":"2052","DOI":"10.1016\/j.bbmt.2015.08.009","article-title":"Suitability Criteria for Adult Related Donors: A Consensus Statement from the Worldwide Network for Blood and Marrow Transplantation Standing Committee on Donor Issues","volume":"21","author":"Worel","year":"2015","journal-title":"Biol Blood Marrow Transplant"},{"issue":"5","key":"10.1016\/j.jcyt.2022.05.009_bib0027","doi-asserted-by":"crossref","first-page":"855","DOI":"10.1007\/s12185-010-0581-1","article-title":"Peripheral blood stem cell versus bone marrow transplantation from HLA-identical sibling donors in patients with leukemia: a propensity score-based comparison from the Japan Society for Hematopoietic Stem Cell Transplantation registry","volume":"91","author":"Nagafuji","year":"2010","journal-title":"Int J Hematol"},{"issue":"2","key":"10.1016\/j.jcyt.2022.05.009_bib0028","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1016\/j.bbmt.2019.09.036","article-title":"Time-Varying Effects of Graft Type on Outcomes for Patients with Acute Myeloid Leukemia Undergoing Allogeneic Hematopoietic Cell Transplantation","volume":"26","author":"Yanada","year":"2020","journal-title":"Biol Blood Marrow Transplant"},{"issue":"2","key":"10.1016\/j.jcyt.2022.05.009_bib0029","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1016\/j.bbmt.2015.09.013","article-title":"Infections after Transplantation of Bone Marrow or Peripheral Blood Stem Cells from Unrelated Donors","volume":"22","author":"Young","year":"2016","journal-title":"Biol Blood Marrow Transplant"},{"issue":"6","key":"10.1016\/j.jcyt.2022.05.009_bib0030","doi-asserted-by":"crossref","first-page":"1452","DOI":"10.1182\/blood-2011-02-321315","article-title":"Small vessels, big trouble in the kidneys and beyond: hematopoietic stem cell transplantation-associated thrombotic microangiopathy","volume":"118","author":"Laskin","year":"2011","journal-title":"Blood"},{"issue":"2","key":"10.1016\/j.jcyt.2022.05.009_bib0031","doi-asserted-by":"crossref","first-page":"300","DOI":"10.1038\/bmt.2010.112","article-title":"Blood stream infection (BSI) and acute GVHD after hematopoietic SCT (HSCT) are associated","volume":"46","author":"Poutsiaka","year":"2011","journal-title":"Bone Marrow Transplant"},{"issue":"3","key":"10.1016\/j.jcyt.2022.05.009_bib0032","doi-asserted-by":"crossref","first-page":"400","DOI":"10.1016\/j.bbmt.2015.09.024","article-title":"Hepatic Veno-Occlusive Disease after Hematopoietic Stem Cell Transplantation: Risk Factors and Stratification, Prophylaxis, and Treatment","volume":"22","author":"Dalle","year":"2016","journal-title":"Biol Blood Marrow Transplant"},{"issue":"6","key":"10.1016\/j.jcyt.2022.05.009_bib0033","doi-asserted-by":"crossref","first-page":"e440","DOI":"10.1097\/MPH.0000000000001795","article-title":"Hemophagocytic Lymphohistiocytosis and Graft Failure Following Unrelated Umbilical Cord Blood Transplantation in Children","volume":"42","author":"Noguchi","year":"2020","journal-title":"J Pediatr Hematol Oncol"},{"issue":"2","key":"10.1016\/j.jcyt.2022.05.009_bib0034","doi-asserted-by":"crossref","first-page":"256","DOI":"10.3324\/haematol.2015.135699","article-title":"Peripheral blood stem cell graft compared to bone marrow after reduced intensity conditioning regimens for acute leukemia: a report from the ALWP of the EBMT","volume":"101","author":"Savani","year":"2016","journal-title":"Haematologica"},{"issue":"4","key":"10.1016\/j.jcyt.2022.05.009_bib0035","doi-asserted-by":"crossref","first-page":"744","DOI":"10.1016\/j.bbmt.2015.12.027","article-title":"Graft-versus-Host Disease after HLA-Matched Sibling Bone Marrow or Peripheral Blood Stem Cell Transplantation: Comparison of North American Caucasian and Japanese Populations","volume":"22","author":"Kanda","year":"2016","journal-title":"Biol Blood Marrow Transplant"},{"issue":"12","key":"10.1016\/j.jcyt.2022.05.009_bib0036","doi-asserted-by":"crossref","first-page":"1583","DOI":"10.1001\/jamaoncol.2016.2520","article-title":"Comparison of Patient-Reported Outcomes in 5-Year Survivors Who Received Bone Marrow vs Peripheral Blood Unrelated Donor Transplantation: Long-term Follow-up of a Randomized Clinical Trial","volume":"2","author":"Lee","year":"2016","journal-title":"JAMA Oncol"},{"issue":"7","key":"10.1016\/j.jcyt.2022.05.009_bib0037","doi-asserted-by":"crossref","first-page":"567","DOI":"10.1016\/j.exphem.2016.04.005","article-title":"Peripheral blood stem cell versus bone marrow transplantation: A perspective from the Acute Leukemia Working Party of the European Society for Blood and Marrow Transplantation","volume":"44","author":"Byrne","year":"2016","journal-title":"Exp Hematol"},{"issue":"12","key":"10.1016\/j.jcyt.2022.05.009_bib0038","doi-asserted-by":"crossref","first-page":"4371","DOI":"10.1182\/blood-2008-03-077974","article-title":"Graft-versus-leukemia effects of transplantation and donor lymphocytes","volume":"112","author":"Kolb","year":"2008","journal-title":"Blood"},{"issue":"2","key":"10.1016\/j.jcyt.2022.05.009_bib0039","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1111\/bjh.17646","article-title":"Residual disease is a strong prognostic marker in patients with acute lymphoblastic leukaemia with chemotherapy-refractory or relapsed disease prior to allogeneic stem cell transplantation","volume":"194","author":"Nakamura","year":"2021","journal-title":"Br J Haematol"},{"issue":"4","key":"10.1016\/j.jcyt.2022.05.009_bib0040","doi-asserted-by":"crossref","first-page":"670","DOI":"10.1182\/bloodadvances.2018027003","article-title":"The impact of the graft-versus-leukemia effect on survival in acute lymphoblastic leukemia","volume":"3","author":"Yeshurun","year":"2019","journal-title":"Blood Adv"},{"issue":"10","key":"10.1016\/j.jcyt.2022.05.009_bib0041","doi-asserted-by":"crossref","first-page":"2942","DOI":"10.1182\/blood.V98.10.2942","article-title":"Antithymocyte globulin for graft-versus-host disease prophylaxis in transplants from unrelated donors: 2 randomized studies from Gruppo Italiano Trapianti Midollo Osseo (GITMO)","volume":"98","author":"Bacigalupo","year":"2001","journal-title":"Blood"},{"issue":"5","key":"10.1016\/j.jcyt.2022.05.009_bib0042","doi-asserted-by":"crossref","first-page":"560","DOI":"10.1016\/j.bbmt.2005.12.034","article-title":"Thymoglobulin prevents chronic graft-versus-host disease, chronic lung dysfunction, and late transplant-related mortality: long-term follow-up of a randomized trial in patients undergoing unrelated donor transplantation","volume":"12","author":"Bacigalupo","year":"2006","journal-title":"Biol Blood Marrow Transplant"},{"issue":"9","key":"10.1016\/j.jcyt.2022.05.009_bib0043","doi-asserted-by":"crossref","first-page":"855","DOI":"10.1016\/S1470-2045(09)70225-6","article-title":"Standard graft-versus-host disease prophylaxis with or without anti-T-cell globulin in haematopoietic cell transplantation from matched unrelated donors: a randomised, open-label, multicentre phase 3 trial","volume":"10","author":"Finke","year":"2009","journal-title":"Lancet Oncol"},{"issue":"3","key":"10.1016\/j.jcyt.2022.05.009_bib0044","doi-asserted-by":"crossref","first-page":"426","DOI":"10.1038\/bmt.2013.191","article-title":"Influence of two different doses of antithymocyte globulin in patients with standard-risk disease following haploidentical transplantation: a randomized trial","volume":"49","author":"Wang","year":"2014","journal-title":"Bone Marrow Transplant"},{"issue":"1","key":"10.1016\/j.jcyt.2022.05.009_bib0045","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1056\/NEJMoa1506002","article-title":"Antilymphocyte Globulin for Prevention of Chronic Graft-versus-Host Disease","volume":"374","author":"Kroger","year":"2016","journal-title":"N Engl J Med"},{"issue":"2","key":"10.1016\/j.jcyt.2022.05.009_bib0046","doi-asserted-by":"crossref","first-page":"e100","DOI":"10.1016\/S2352-3026(19)30220-0","volume":"7","author":"Walker","year":"2020","journal-title":"Lancet Haematol"},{"issue":"4","key":"10.1016\/j.jcyt.2022.05.009_bib0047","doi-asserted-by":"crossref","first-page":"643","DOI":"10.1111\/bjh.15131","volume":"184","author":"Ofran","year":"2019","journal-title":"Br J Haematol"},{"issue":"23","key":"10.1016\/j.jcyt.2022.05.009_bib0048","doi-asserted-by":"crossref","first-page":"6375","DOI":"10.1182\/blood-2011-01-329821","article-title":"Chronic graft-versus-host disease: long-term results from a randomized trial on graft-versus-host disease prophylaxis with or without anti-T-cell globulin ATG-Fresenius","volume":"117","author":"Socie","year":"2011","journal-title":"Blood"},{"issue":"13","key":"10.1016\/j.jcyt.2022.05.009_bib0049","doi-asserted-by":"crossref","first-page":"1950","DOI":"10.1182\/bloodadvances.2019000030","article-title":"Impact of antithymocyte globulin on outcomes of allogeneic hematopoietic cell transplantation with TBI","volume":"3","author":"Nagler","year":"2019","journal-title":"Blood Adv"},{"issue":"36","key":"10.1016\/j.jcyt.2022.05.009_bib0050","doi-asserted-by":"crossref","first-page":"4003","DOI":"10.1200\/JCO.2017.75.8177","article-title":"Prospective, Randomized, Double-Blind, Phase III Clinical Trial of Anti-T-Lymphocyte Globulin to Assess Impact on Chronic Graft-Versus-Host Disease-Free Survival in Patients Undergoing HLA-Matched Unrelated Myeloablative Hematopoietic Cell Transplantation","volume":"35","author":"Soiffer","year":"2017","journal-title":"J Clin Oncol"},{"issue":"9","key":"10.1016\/j.jcyt.2022.05.009_bib0051","doi-asserted-by":"crossref","first-page":"2231","DOI":"10.1038\/s41409-021-01314-w","article-title":"Low-dose antithymocyte globulin inhibits chronic graft-versus-host disease in peripheral blood stem cell transplantation from unrelated donors","volume":"56","author":"Shiratori","year":"2021","journal-title":"Bone Marrow Transplant"},{"issue":"9","key":"10.1016\/j.jcyt.2022.05.009_bib0052","doi-asserted-by":"crossref","first-page":"1422","DOI":"10.1016\/j.bbmt.2012.02.013","volume":"18","author":"Nagler","year":"2012","journal-title":"Biol Blood Marrow Transplant"},{"issue":"6","key":"10.1016\/j.jcyt.2022.05.009_bib0053","doi-asserted-by":"crossref","first-page":"684","DOI":"10.1007\/s12185-019-02631-z","article-title":"Short-term clinical outcomes after HLA 1-locus mismatched uPBSCT are similar to that after HLA-matched uPBSCT and uBMT","volume":"109","author":"Fuji","year":"2019","journal-title":"Int J Hematol"},{"issue":"17","key":"10.1016\/j.jcyt.2022.05.009_bib0054","doi-asserted-by":"crossref","first-page":"1177","DOI":"10.1056\/NEJM199810223391701","article-title":"Effect of matching of class I HLA alleles on clinical outcome after transplantation of hematopoietic stem cells from an unrelated donor. Japan Marrow Donor Program","volume":"339","author":"Sasazuki","year":"1998","journal-title":"N Engl J Med"},{"issue":"3","key":"10.1016\/j.jcyt.2022.05.009_bib0055","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1016\/j.bbmt.2014.12.001","article-title":"National Institutes of Health Consensus Development Project on Criteria for Clinical Trials in Chronic Graft-versus-Host Disease: I. The 2014 Diagnosis and Staging Working Group report","volume":"21","author":"Jagasia","year":"2015","journal-title":"Biol Blood Marrow Transplant"}],"container-title":["Cytotherapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1465324922006740?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1465324922006740?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,26]],"date-time":"2025-10-26T01:47:29Z","timestamp":1761443249000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1465324922006740"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,10]]},"references-count":55,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2022,10]]}},"alternative-id":["S1465324922006740"],"URL":"https:\/\/doi.org\/10.1016\/j.jcyt.2022.05.009","relation":{},"ISSN":["1465-3249"],"issn-type":[{"value":"1465-3249","type":"print"}],"subject":[],"published":{"date-parts":[[2022,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Advantages of peripheral blood stem cells from unrelated donors versus bone marrow transplants in outcomes of adult acute myeloid leukemia patients","name":"articletitle","label":"Article Title"},{"value":"Cytotherapy","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jcyt.2022.05.009","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 International Society for Cell & Gene Therapy. Published by Elsevier Inc.","name":"copyright","label":"Copyright"}]}}